Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Am J Gastroenterol
1 BMC Gastroenterol
1 Gut
2 Hepatology
3 J Hepatol
1 J Infect Dis
1 J Med Virol
4 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. GHANY MG, Saraswat VA
    Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002224.
    PubMed         Abstract available

    BMC Gastroenterol

  2. XIONG Y, Xia Z, Yang L, Huang J, et al
    A novel nomogram to predict 90-day mortality in patients with hepatitis B virus-related acute-on-chronic liver failure: a single-center retrospective study.
    BMC Gastroenterol. 2023;23:86.
    PubMed         Abstract available


    First hepatitis D medicine is given restricted approval in Scotland after US rejection.
    BMJ. 2023;380:p660.


  4. GIRALDEZ-GALLEGO A, Rodriguez-Seguel EDP, Valencia-Martin R, Morillo-Garcia A, et al
    Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial.
    Gut. 2023 Mar 24:gutjnl-2022-328222. doi: 10.1136/gutjnl-2022-328222.
    PubMed         Abstract available


  5. TAN DJH, Setiawan VW, Ng CH, Lim WH, et al
    Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
    Hepatology. 2023;77:1150-1163.
    PubMed         Abstract available

  6. LEE HM, Lidofsky SD, Taddei TH, Townshend-Bulson LJ, et al
    Attacking the Public Health Crisis of Hepatocellular Carcinoma at its Roots.
    Hepatology. 2022 Aug 21. doi: 10.1002/hep.32741.

    J Hepatol

  7. CAMINADA S, Mele A, Ferrigno L, Alfonsi V, et al
    Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021.
    J Hepatol. 2023 Mar 17:S0168-8278(23)00177-0. doi: 10.1016/j.jhep.2023.
    PubMed         Abstract available

  8. WANG L, Zhu Q, Zhang JD, Zhang Y, et al
    Discovery of a first-in-class orally available HBV cccDNA inhibitor.
    J Hepatol. 2023;78:742-753.
    PubMed         Abstract available

  9. ZHANG F, Xu LD, Zhang Q, Wang A, et al
    Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
    J Hepatol. 2023;78:704-716.
    PubMed         Abstract available

    J Infect Dis

  10. GAMKRELIDZE A, Shadaker S, Tsereteli M, Alkhazashvili M, et al
    Nationwide hepatitis C serosurvey and progress towards HCV elimination in the country of Georgia, 2021.
    J Infect Dis. 2023 Mar 18:jiad064. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  11. CHEN Z, Huang T, He T, Zha G, et al
    Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28695.
    PubMed         Abstract available

    N Engl J Med

  12. DUSHEIKO G, Agarwal K, Maini MK
    New Approaches to Chronic Hepatitis B. Reply.
    N Engl J Med. 2023;388:1148-1149.

  13. TSENG TC, Kao JH
    New Approaches to Chronic Hepatitis B.
    N Engl J Med. 2023;388:1148.

  14. YUEN MF, Elston R, Theodore D
    Efficacy and Safety of Bepirovirsen in Hepatitis B. Reply.
    N Engl J Med. 2023;388:1147-1148.

    Efficacy and Safety of Bepirovirsen in Hepatitis B.
    N Engl J Med. 2023;388:1146-1147.

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.